NCT02490969

Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,256 (actual)
• Sponsor: Charite University, Berlin, Germany · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Registry of an interventional Study-proved Strategy (BIC-8) using Copeptin and Troponin for the Early Rule-Out of Acute Myocardial Infarction (AMI) in Patients with Suspected Acute Coronary Syndrome (ACS) and a low-to intermediate risk profile.

Detailed description

Registry of an interventional Study-proved Strategy (BIC-8) using Copeptin and Troponin for the Early Rule-Out of Acute Myocardial Infarction (AMI) in Patients with Suspected Acute Coronary Syndrome (ACS) and a low-to intermediate risk profile. Primary objective: To monitor the safety of the early rule-out strategy using combined testing of copeptin and troponin at admission of patients with signs and symptoms suggestive of ACS and a low- to intermediate risk profile, who are discharged or moved to another hospital after testing copeptin and troponin negative (defined as copeptin below 10 pmol/l and cardiac troponin below 99th percentile URL). Secondary objectives: * To monitor routine application of the early rule-out strategy, patient characteristics, risk profile of all patients tested for copeptin and troponin at admission, irrespective of their biomarker test result * To monitor diagnoses, clinical course and outcome of all patients tested for copeptin and troponin at admission

Conditions

• Acute Myocardial Infarction

Interventions

Type	Name	Description
PROCEDURE	Routine management observation	Early rule out of myocardial infarction with combined copetine and troponin testing at admission

Timeline

• Start date: 2015-09-01
• Primary completion: 2017-05-23
• Completion: 2017-05-23
• First posted: 2015-07-07
• Last updated: 2017-05-24

Locations

1 site across 1 country: Germany